Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-13 11:55:42 UTC |
---|
Update Date | 2022-03-07 02:57:15 UTC |
---|
HMDB ID | HMDB0042043 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Tolfenamic acid |
---|
Description | Tolfenamic acid, also known as acido tolfenamico or tolfenamate, belongs to the class of organic compounds known as aminobenzoic acids. These are benzoic acids containing an amine group attached to the benzene moiety. Based on a literature review a significant number of articles have been published on Tolfenamic acid. |
---|
Structure | CC1=C(Cl)C=CC=C1NC1=CC=CC=C1C(O)=O InChI=1S/C14H12ClNO2/c1-9-11(15)6-4-8-12(9)16-13-7-3-2-5-10(13)14(17)18/h2-8,16H,1H3,(H,17,18) |
---|
Synonyms | Value | Source |
---|
Acide tolfenamique | ChEBI | Acido tolfenamico | ChEBI | Acidum tolfenamicum | ChEBI | N-(2-Methyl-3-chlorophenyl)anthranilic acid | ChEBI | N-(3-Chloro-2-methylphenyl)anthranilic acid | ChEBI | N-(3-Chloro-O-tolyl)-anthranilic acid | ChEBI | N-(2-Methyl-3-chlorophenyl)anthranilate | Generator | N-(3-Chloro-2-methylphenyl)anthranilate | Generator | N-(3-Chloro-O-tolyl)-anthranilate | Generator | Tolfenamate | Generator | Clotam | HMDB | Pharmacia brand OF tolfenamic acid | HMDB | Rociclyn | HMDB | Bifenac | HMDB | N-(3-Chloro-O-tolyl)anthranilic acid | HMDB | Provalis brand OF tolfenamic acid | HMDB | Zambon brand OF tolfenamic acid | HMDB |
|
---|
Chemical Formula | C14H12ClNO2 |
---|
Average Molecular Weight | 261.704 |
---|
Monoisotopic Molecular Weight | 261.05565634 |
---|
IUPAC Name | 2-[(3-chloro-2-methylphenyl)amino]benzoic acid |
---|
Traditional Name | tolfenamic acid |
---|
CAS Registry Number | 13710-19-5 |
---|
SMILES | CC1=C(Cl)C=CC=C1NC1=CC=CC=C1C(O)=O |
---|
InChI Identifier | InChI=1S/C14H12ClNO2/c1-9-11(15)6-4-8-12(9)16-13-7-3-2-5-10(13)14(17)18/h2-8,16H,1H3,(H,17,18) |
---|
InChI Key | YEZNLOUZAIOMLT-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as aminobenzoic acids. These are benzoic acids containing an amine group attached to the benzene moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Benzoic acids and derivatives |
---|
Direct Parent | Aminobenzoic acids |
---|
Alternative Parents | |
---|
Substituents | - Aminobenzoic acid
- Benzoic acid
- Benzoyl
- Aniline or substituted anilines
- Aminotoluene
- Chlorobenzene
- Halobenzene
- Toluene
- Aryl chloride
- Aryl halide
- Vinylogous amide
- Amino acid or derivatives
- Amino acid
- Secondary amine
- Carboxylic acid derivative
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Organooxygen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Organohalogen compound
- Amine
- Organic oxygen compound
- Organic oxide
- Organopnictogen compound
- Organochloride
- Organonitrogen compound
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 207 - 207.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | 5.17 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Tolfenamic acid,1TMS,isomer #1 | CC1=C(Cl)C=CC=C1NC1=CC=CC=C1C(=O)O[Si](C)(C)C | 2264.4 | Semi standard non polar | 33892256 | Tolfenamic acid,1TMS,isomer #2 | CC1=C(Cl)C=CC=C1N(C1=CC=CC=C1C(=O)O)[Si](C)(C)C | 2179.4 | Semi standard non polar | 33892256 | Tolfenamic acid,2TMS,isomer #1 | CC1=C(Cl)C=CC=C1N(C1=CC=CC=C1C(=O)O[Si](C)(C)C)[Si](C)(C)C | 2197.3 | Semi standard non polar | 33892256 | Tolfenamic acid,2TMS,isomer #1 | CC1=C(Cl)C=CC=C1N(C1=CC=CC=C1C(=O)O[Si](C)(C)C)[Si](C)(C)C | 2264.7 | Standard non polar | 33892256 | Tolfenamic acid,1TBDMS,isomer #1 | CC1=C(Cl)C=CC=C1NC1=CC=CC=C1C(=O)O[Si](C)(C)C(C)(C)C | 2510.7 | Semi standard non polar | 33892256 | Tolfenamic acid,1TBDMS,isomer #2 | CC1=C(Cl)C=CC=C1N(C1=CC=CC=C1C(=O)O)[Si](C)(C)C(C)(C)C | 2427.4 | Semi standard non polar | 33892256 | Tolfenamic acid,2TBDMS,isomer #1 | CC1=C(Cl)C=CC=C1N(C1=CC=CC=C1C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2661.1 | Semi standard non polar | 33892256 | Tolfenamic acid,2TBDMS,isomer #1 | CC1=C(Cl)C=CC=C1N(C1=CC=CC=C1C(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2635.4 | Standard non polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Tolfenamic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-029f-0290000000-193c55add3bbbb7d5121 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tolfenamic acid GC-MS (1 TMS) - 70eV, Positive | splash10-00dl-9354000000-172c43eaed1235f269a7 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Tolfenamic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Tolfenamic acid , positive-QTOF | splash10-0006-1290000000-90928e5629bf0b4869e8 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Tolfenamic acid , positive-QTOF | splash10-0a59-2790000000-175a0f838779d665e3db | 2017-09-14 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tolfenamic acid 10V, Positive-QTOF | splash10-03di-0090000000-9e173e701dad784002bf | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tolfenamic acid 20V, Positive-QTOF | splash10-02vl-0490000000-383bb531cf3b364e8551 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tolfenamic acid 40V, Positive-QTOF | splash10-004i-3920000000-f62680abb4f65b264811 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tolfenamic acid 10V, Negative-QTOF | splash10-02t9-0090000000-a116f61548e6965f47fe | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tolfenamic acid 20V, Negative-QTOF | splash10-014i-0190000000-d6c269ae6e8f165e1af8 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tolfenamic acid 40V, Negative-QTOF | splash10-00l6-7970000000-7e83c63a8f674eb4dbb1 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tolfenamic acid 10V, Negative-QTOF | splash10-03di-0090000000-f1e193bda03b4aaed004 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tolfenamic acid 20V, Negative-QTOF | splash10-014i-2190000000-2fcbcc8f4250abae18dd | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tolfenamic acid 40V, Negative-QTOF | splash10-001i-9000000000-c2fa753da65a4bac80a1 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tolfenamic acid 10V, Positive-QTOF | splash10-01ox-0090000000-d9fc45f2fd3466ad4bb4 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tolfenamic acid 20V, Positive-QTOF | splash10-0006-0090000000-8d746ea562322ef5c27a | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Tolfenamic acid 40V, Positive-QTOF | splash10-053r-0950000000-1f2515f699ddfef235a4 | 2021-09-22 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | - Membrane (predicted from logP)
|
---|
Biospecimen Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| Not Available |
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | DB09216 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 530683 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Tolfenamic_acid |
---|
METLIN ID | Not Available |
---|
PubChem Compound | 610479 |
---|
PDB ID | TLF |
---|
ChEBI ID | 32243 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Eslin D, Sankpal UT, Lee C, Sutphin RM, Maliakal P, Currier E, Sholler G, Khan M, Basha R: Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: a novel therapeutic agent for neuroblastoma. Mol Carcinog. 2013 May;52(5):377-86. doi: 10.1002/mc.21866. Epub 2011 Dec 28. [PubMed:22213339 ]
- Chadalapaka G, Jutooru I, Sreevalsan S, Pathi S, Kim K, Chen C, Crose L, Linardic C, Safe S: Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors. Int J Cancer. 2013 Feb 15;132(4):795-806. doi: 10.1002/ijc.27730. Epub 2012 Aug 3. [PubMed:22815231 ]
- Sutphin RM, Connelly SF, Lee CM, Sankpal UT, Eslin D, Khan M, Pius H, Basha R: Anti-leukemic response of a NSAID, tolfenamic acid. Target Oncol. 2014 Jun;9(2):135-44. doi: 10.1007/s11523-013-0274-9. Epub 2013 Apr 23. [PubMed:23609055 ]
- Subaiea GM, Adwan LI, Ahmed AH, Stevens KE, Zawia NH: Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease mice. Neurobiol Aging. 2013 Oct;34(10):2421-30. doi: 10.1016/j.neurobiolaging.2013.04.002. Epub 2013 Apr 30. [PubMed:23639209 ]
- Eslin D, Lee C, Sankpal UT, Maliakal P, Sutphin RM, Abraham L, Basha R: Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study. Tumour Biol. 2013 Oct;34(5):2781-9. doi: 10.1007/s13277-013-0836-6. Epub 2013 May 18. [PubMed:23686785 ]
- Jeong JB, Yang X, Clark R, Choi J, Baek SJ, Lee SH: A mechanistic study of the proapoptotic effect of tolfenamic acid: involvement of NF-kappaB activation. Carcinogenesis. 2013 Oct;34(10):2350-60. doi: 10.1093/carcin/bgt224. Epub 2013 Jun 19. [PubMed:23784084 ]
- Nadanaciva S, Aleo MD, Strock CJ, Stedman DB, Wang H, Will Y: Toxicity assessments of nonsteroidal anti-inflammatory drugs in isolated mitochondria, rat hepatocytes, and zebrafish show good concordance across chemical classes. Toxicol Appl Pharmacol. 2013 Oct 15;272(2):272-80. doi: 10.1016/j.taap.2013.06.019. Epub 2013 Jun 26. [PubMed:23811329 ]
- Zhang X, Min KW, Liggett J, Baek SJ: Disruption of the transforming growth factor-beta pathway by tolfenamic acid via the ERK MAP kinase pathway. Carcinogenesis. 2013 Dec;34(12):2900-7. doi: 10.1093/carcin/bgt250. Epub 2013 Jul 16. [PubMed:23864386 ]
- Kim HJ, Cho SD, Kim J, Kim SJ, Choi C, Kim JS, Nam JS, Han Kwon K, Kang KS, Jung JY: Apoptotic effect of tolfenamic acid on MDA-MB-231 breast cancer cells and xenograft tumors. J Clin Biochem Nutr. 2013 Jul;53(1):21-6. doi: 10.3164/jcbn.12-78. Epub 2013 Jun 29. [PubMed:23874066 ]
- Jeong JB, Choi J, Baek SJ, Lee SH: Reactive oxygen species mediate tolfenamic acid-induced apoptosis in human colorectal cancer cells. Arch Biochem Biophys. 2013 Sep 15;537(2):168-75. doi: 10.1016/j.abb.2013.07.016. Epub 2013 Jul 26. [PubMed:23896517 ]
|
---|